Voyages pour PME Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
Viaggi per imprenditori Prospettive dell’idrogeno: alla scoperta del settore delle energie rinnovabili in Marocco 09 Giu 2024–13 Giu 2024 Marocco
Fact-Finding Mission Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
News 23 Apr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News 17 Apr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
Unternehmerreisen Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mag 2024–16 Mag 2024 Armenia
Viaggi per imprenditori Fact finding mission: galleria di base del Brennero 17 Giu 2024–18 Giu 2024 Innsbruck Austria
News 04 Apr 2024 Legartis and Implenia automate contract reviews in the construction industry Legartis and Implenia are aiming to shorten the amount of time spent reviewing comprehensive contracts in the construction industry. Legartis, wh...
Fact-Finding Mission Fact Finding Mission to the Brenner Basis Tunnel 17 Giu 2024–18 Giu 2024 Innsbruck Austria
Actualités 17 Apr 2024 Symbio va investir CHF 12 millions dans un nouveau centre de recherche à Corminboeuf Symbio va consacrer CHF 12 millions pour construire un centre de recherche de pointe sur l’hydrogène à Corminboeuf, avec un lancement prévu en 20...
Registrazioni video 18 Gen 2024 Cogliere le opportunità dell'industria ferroviaria coreana Guardate la registrazione del nostro webinar esclusivo sull'industria ferroviaria coreana, dove la storia incontra la tecnologia d'avanguardia. S...
Actualités 17 Apr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...